Quick Answer
BiomX Inc. reported Cash and Equivalents of $4.36 million for fiscal year 2025.
BiomX Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $4.36M | -74.1% |
| 2024 | $16.86M | +13.1% |
| 2023 | $14.91M | -52.4% |
| 2022 | $31.33M | -49.5% |
| 2021 | $62.10M | +70.2% |
| 2020 | $36.48M | -49.5% |
| 2019 | $72.26M | +10269.2% |
| 2019 | $696.8K | -91.9% |
| 2018 | $8.60M | +2000830.2% |
| 2018 | $430.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.92M | -70.6% | -50.7% |
| June 30, 2025 | $14.05M | -55.6% | -30.2% |
| March 31, 2025 | $20.12M | -53.2% | +19.3% |
| December 31, 2024 | $16.86M | +13.1% | -28.4% |
| September 30, 2024 | $23.54M | +4.8% | -25.5% |
| June 30, 2024 | $31.61M | +6.4% | -26.5% |
| March 31, 2024 | $43.01M | +46.6% | +188.5% |
| December 31, 2023 | $14.91M | -52.4% | -33.6% |
- BiomX Inc. showed a decrease of -74.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, BiomX Inc.’s cash and equivalents has grown by 1013853.5% (from $430.00 to $4.36 million).
- The most recent figure is from BiomX Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: